Recent cocaine use decreases negative signs in acute schizophrenia: A case study over two consecutive admissions

Biological Psychiatry

Volumn 39, Issue 9, 1996, Pages 816-818

  Serper, Mark R ^a   Alpert, Murray ^a   Trujillo, Manuel ^a  

^a BELLEVUE HOSPITAL CENTER   (United States)

Author keywords

Cocaine comorbidity; Negative symptoms; Neuropsychopharmacology; Schizophrenia

Indexed keywords

COCAINE;

ADULT; ARTICLE; CASE REPORT; FEMALE; HUMAN; NEGATIVE SYNDROME; PRIORITY JOURNAL; SCHIZOPHRENIA; SUBSTANCE ABUSE;

EID: 0029951092     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-3223(95)00591-9     Document Type: Article

References (17)

1. Andreasen N (1984a): Scale for the Assessment of Positive Symptoms. Iowa City, IA: University of Iowa.
2. Andreasen N (1984b): Scale for the Assessment of Negative Symptoms. Iowa City, IA: University of Iowa.
3. Andreasen NC, Flaum M, Arndt S (1992): The comprehensive assessment of symptoms and history (Cash): An instrument for assessing diagnosis and psychopathology. Arch Gen Psychiatry 49:615-623.
4. Angrist B, Peselow E, Rubinstein M, Corwin J, Rotrosen J (1982): Partial improvement in negative symptoms after amphetamine. Psychopharmacology 78:128-130.
5. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961): An inventory for measuring depression. Arch Gen Psychiatry 4:53-63.
6. Dixon L, Haas G, Weiden P, Sweeney J, Francis A (1990): Acute effects of drugs of abuse in schizophrenia patients: Clinical observations and patients' self-reports. Schizophr Bull 16:69-79.
7. Dixon L, Haas G, Weiden P, Sweeney J, Francis A (1991): Drug abuse in schizophrenic patients: Clinical correlates and reasons for use. Am J Psychiatry 148:224-230.
8. Goldberg TE, Bigelow G, Weinberger D (1991): Cognitive and behavioral effects on coadministration of dextroamphetamine and haloperidol in schizophrenia. Am J Psychiatry 148:78-84.
9. Lysaker P, Bell M, Beam-Goulet J, Milstein R (1994): Relationship of positive and negative symptoms to cocaine abuse in schizophrenia. J Nerv Ment Dis 182:109-112.
10. Mueser KT, Douglas MS, Bellack AS, Morrison RL (1991): Assessment of enduring deficit and negative symptom subtypes in schizophrenia. Schizophr Bull 17:565-582.
11. Mueser KT, Bellack AS, Blanchard J (1992): Comorbidity of schizophrenia and substance abuse: Implications for treatment. J Consult Clin Psychology 60:845-856.
12. Overall JE, Gorham DR (1962): The brief psychiatric rating scale. Psychol Rep 10:799-812.
13. Schneider FR, Siris SG (1987): A review of psychoactive substance use and abuse in schizophrenia: Patterns of drug choice. J Nerv Ment Dis 175:641-652.
14. Serper MR, Alpert M, Richardson N, Dickson S, Allen M, Werner A (1995): Clinical effects of recent cocaine use in acute schizophrenia. Am J Psychiatry 152:1464-1469.
15. Shrout PE, Fleiss JL (1979): Intraclass correlations: Uses in assessing rater reliability. Psychol Bull 86:420-428.
16. Spitzer RL, Williams JBW, Gibbon M, First MB (1990): Structured Clinical Interview for DSM-III-R-Patient Edition (SCID-P, Version 1.0). Washington, DC: American Psychiatric Press.
17. Tsuang MT, Simpson JC, Kronfol Z (1982): Subtypes of drug abuse with psychosis. Arch Gen Psychiatry 39:141-147.